Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Charles Andrew Butts, Mark A. Socinski, Paul L R Mitchell et al. · The Lancet Oncology · 2013

Cited by 538 works. doi:10.1016/s1470-2045(13)70510-2

Authors

References